Bladder Carcinoma Clinical Trials

A listing of Bladder Carcinoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 260 clinical trials
Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable

This is a phase II study to determine the safety and efficacy of tislelizumab when given in combination with nab-paclitaxel as treatment for patients with high-risk non-muscle-invasive bladder cancer (HR NMIBC) which is not completely resectable. Patients will receive treatment with tislelizumab in combination with nab-paclitaxel every 3 weeks for …

  • 0 views
  • 06 Nov, 2021
  • 1 location
hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study"

Cabozantinib plus Durvalumab in patients with advanced and chemotherapy-treated bladder carcinoma, of urothelial and non-urothelial histology: an open-label, single-centre, phase 2, single-arm

  • 0 views
  • 04 Mar, 2021
  • 1 location
Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection

This prospective, open-Label, comparative, randomized, controlled phase III trial was designed to compare the clinical performance of gemcitabine with capecitabine vs. capecitabine alone for patients with biliary tract cancer (BTC) after curative resection.

  • 0 views
  • 22 Jan, 2021
  • 1 location
Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Study of Chidamide Combined With Immunotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Who Had Previously Received Platinum-based Chemotherapy

  • 8 views
  • 26 Jan, 2021
  • 1 location
Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery

This phase III trial studies how well nutrition therapy works in improving immune system in patients with bladder cancer that can be removed by surgery. Improving nutrition before and after surgery may reduce the infections and other problems that sometimes occur after surgery.

transurethral bladder excision
carcinoma
bladder tumor
transurethral resection
radical cystectomy
  • 6 views
  • 11 Feb, 2022
  • 32 locations
Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC

Investigators will evaluate the safety and efficacy of combination neoadjuvant therapy using intravesical CG0070 and IV Nivolumab in cisplatin ineligible patients with Muscle Invasive Bladder Cancer (MIBC).

cg0070
carcinoma
bladder tumor
nivolumab
neutrophil count
  • 0 views
  • 12 Jul, 2022
  • 1 location
DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr (DURANCE)

DURANCE is a two part, phase Ib/II, multi-centre study to assess the safety and activity of S-488210/S-488211 in combination with durvalumab, in patients with non-muscle invasive bladder cancer (NMIBC).

invasive bladder cancer
gilbert's syndrome
carcinoma
bladder tumor
neutrophil count
  • 0 views
  • 30 Apr, 2022
  • 1 location
Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC

Current treatment of localized muscle-invasive bladder cancer is still associated with high relapse and death rate as well as the need for complete bladder resection or irradiation. The primary objective of this trial is to increase the rate of pathologic complete remission (pCR) at the time of radical cystectomy by …

bladder instillation
invasive bladder cancer
gemcitabine
carcinoma
EGFR
  • 0 views
  • 13 Jul, 2022
  • 9 locations
Care Planning Framework in Advanced Bladder Cancer (ABC123)

Pilot study assessing the feasibility and acceptability of the ABC123 framework, as well as goal concordance between patient and clinician stated goals. Patients >60 years old with recently diagnosed advanced, incurable bladder cancer making an initial treatment decision will be enrolled. The team will pilot test the ABC123 framework delivery …

bladder tumor
carcinoma
  • 0 views
  • 14 Jun, 2022
  • 1 location
Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM) (HIRACOM)

The purpose of this study is to investigate the side effects, quality of life, and treatment effects of concurrent chemo-hypofractionated intensity-modulated radiation therapy in bladder cancer. Twenty fractionation within 4 weeks are performed using hypofractionated intensity-modulated radiation therapy. As for the radiation dose, 2.8-3.2 Gy at a time, total dose …

invasive bladder cancer
bladder tumor
carboplatin
metastasis
transurethral resection
  • 0 views
  • 24 Jul, 2022
  • 1 location